RIG-I activation inhibits ebolavirus replication

Virology

Volumn 392, Issue 1, 2009, Pages 11-15

  Spiropoulou, Christina F ^a   Ranjan, Priya ^b   Pearce, Melissa B ^b   Sealy, Tara K ^a   Albariño, César G ^a   Gangappa, Shivaprakash ^b   Fujita, Takashi ^c   Rollin, Pierre E ^a   Nichol, Stuart T ^a   Ksiazek, Thomas G ^a   Sambhara, Suryaprakash ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Ebolavirus; RIG I

Indexed keywords

BETA INTERFERON; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS HEMORRHAGIC FEVER; VIRUS REPLICATION; VIRUS VIRULENCE;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; EBOLAVIRUS; HUMANS; IMMUNITY, INNATE; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; RNA, VIRAL; VIRUS REPLICATION;

EBOLA VIRUS; MARBURGVIRUS;

EID: 69249202248     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.06.032     Document Type: Article

References (28)

1. Basler C.F., Mikulasova A., Martinez-Sobrido L., Paragas J., Mühlberger E., Bray M., Klenk H.D., Palese P., and García-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77 (2003) 7945-7956
2. Bowie A.G., and Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signaling. Nat. Rev., Immunol. 8 (2008) 911-922
3. Cárdenas W.B., Loo Y.M., Gale Jr. M., Hartman A.L., Kimberlin C.R., Martínez-Sobrido L., Saphire E.O., and Basler C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80 (2006) 5168-5178
4. Castanotto D., and Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 457 (2009) 426-433
5. Feng Z., Cerveny M., Yan Z., and He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J. Virol. 81 (2007) 182-192
6. Haasnoot J., de Vries W., Geutjes E.J., Prins M., de Haan P., and Berkhout B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3 (2007) e86
7. Habjan M., Andersson I., Klingström J., Schümann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Mühlberger E., Mirazimi A., and Weber F. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3 (2008) e2032
8. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., and Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
9. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., and Hartmann G. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
10. Jahrling P.B., Geisbert T.W., Geisbert J.B., Swearengen J.R., Bray M., Jaax N.K., Huggins J.W., LeDuc J.W., and Peters C.J. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect Dis. 179 Suppl 1 (1999) S224-234
11. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., and Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441 (2006) 101-105
12. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., and Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22 (2004) 321-325
13. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., and Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203 (2006) 1795-1803
14. Paragas J., and Geisbert T.W. Development of treatment strategies to combat Ebola and Marburg viruses. Expert Rev. Anti. Infect. Ther. 4 (2006) 67-76
15. Pichlmair A., Schulz O., Tan C.P., Näslund T.I., Liljeström P., Weber F., and Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006) 997-1001
16. Prins K.C., Cárdenas W.B., and Basler C.F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 83 (2009) 3069-3077
17. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., and Basler C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80 (2006) 5156-5167
18. Saito T., Owen D.M., Jiang F., Marcotrigiano J., and Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 454 (2008) 523-527
19. Sanchez A., Lukwiya M., Bausch D., Mahanty S., Sanchez A.J., Wagoner K.D., and Rollin P.E. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol. 78 (2004) 10370-10377
20. Sanchez A., Geisbert T.W., and Feldmann H. In: Knipe D.M.H., and Peter M. (Eds). Fields Virology vol. 2 (2007), Lippincott Williams and Wilkins, 530 Walnut Street, Philadelphia, PA 19106 USA 1410-1448
21. Spurgers K.B., Sharkey C.M., Warfield K.L., and Bavari S. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res. 78 (2008) 26-36
22. Ströher U., Willihnganz L., Jean F., and Feldmann H. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. J. Infect. Dis. 196 Suppl. 2 (2007) S271-275
23. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., Narita R., Gale Jr. M., Inagaki F., and Fujita T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell. 29 (2008) 428-440
24. Takeuchi O., and Akira S. Innate immunity to virus infection. Immunol Rev. 227 (2009) 75-86
25. Towner J.S., Rollin P.E., Bausch D.G., Sanchez A., Crary S.M., Vincent M., Lee W.F., Spiropoulou C.F., Ksiazek T.G., Lukwiya M., Kaducu F., Downing R., and Nichol S.T. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J. Virol. 78 (2004) 4330-4341
26. Towner J.S., Sealy T.K., Khristova M.L., Albariño C.G., Conlan S., Reeder S.A., Quan P.L., Lipkin W.I., Downing R., Tappero J.W., Okware S., Lutwama J., Bakamutumaho B., Kayiwa J., Comer J.A., Rollin P.E., Ksiazek T.G., and Nichol S.T. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4 (2008) e1000212
27. Warfield K.L., Swenson D.L., Olinger G.G., Nichols D.K., Pratt W.D., Blouch R., Stein D.A., Aman M.J., Iversen P.L., and Bavari S. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog 2 (2006) e1
28. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737